DARAPRIM Drug Patent Profile
✉ Email this page to a colleague
When do Daraprim patents expire, and what generic alternatives are available?
Daraprim is a drug marketed by Tilde Sciences and is included in one NDA.
The generic ingredient in DARAPRIM is pyrimethamine. There are three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pyrimethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Daraprim
A generic version of DARAPRIM was approved as pyrimethamine by SANALUZ on February 28th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DARAPRIM?
- What are the global sales for DARAPRIM?
- What is Average Wholesale Price for DARAPRIM?
Summary for DARAPRIM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 128 |
| Clinical Trials: | 8 |
| Patent Applications: | 3,846 |
| Drug Prices: | Drug price information for DARAPRIM |
| What excipients (inactive ingredients) are in DARAPRIM? | DARAPRIM excipients list |
| DailyMed Link: | DARAPRIM at DailyMed |
Recent Clinical Trials for DARAPRIM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Washington University School of Medicine | Early Phase 1 |
| University of Kansas Medical Center | Phase 1 |
| Montefiore Medical Center | Phase 1 |
Pharmacology for DARAPRIM
| Drug Class | Dihydrofolate Reductase Inhibitor Antimalarial |
| Mechanism of Action | Dihydrofolate Reductase Inhibitors |
US Patents and Regulatory Information for DARAPRIM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tilde Sciences | DARAPRIM | pyrimethamine | TABLET;ORAL | 008578-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
